Upgrade to SI Premium - Free Trial

Jefferies Raises Price Target on Celldex (CLDX) to $5 Following 2Q; Reiterates Hold

August 9, 2016 9:44 AM
Jefferies reiterated a Hold rating on Celldex Therapeutics (NASDAQ: CLDX), and raised the price target to $5.00 (from $4.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles